Application of Jasmine flower extract in regulating intestinal flora and improving metabolic syndrome

Through the olive glycoside in frangipani extract, the intestinal bacterial flora is regulated and the enrichment of Parabacteroides is enriched, the side effects and individual needs of existing obesity treatment methods are solved, and effective improvement of metabolic syndrome is achieved. New Chinese medicine resources and medicinal ingredients.

CN116407580BActive Publication Date: 2024-11-12JIANGXI ZHANGBANG PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310321047.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-28
Publication Date
2024-11-12
Estimated Expiration
2043-03-28

AI Technical Summary

Technical Problem

There are side effects or individual needs for existing obesity treatments, and there is a lack of effective Chinese medicine resources to regulate intestinal flora and improve metabolic syndrome.

Method used

Frangipani extract, especially oleuropein, is used to enrich Parabens Kinderella by regulating the intestinal microbiota structure. It is used as a drug to prevent or treat metabolic syndrome and intestinal microbiota disorders. It is used as a drug for the prevention or treatment of metabolic syndrome and intestinal microbiota disorders. Source" characteristics as a ingredient in Chinese medicine.

Benefits of technology

Effectively regulate the intestinal flora of obese mice, significantly enrich Parabacteroides, improve metabolic syndrome, reduce relevant metabolic disease indicators, and have no obvious toxic side effects, providing new Chinese medicine resources and medicinal ingredients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116407580B_ABST
    Figure CN116407580B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of medical technology, and discloses an application of a jasmine flower extract in regulating intestinal flora and improving metabolic syndrome. The present invention applies the jasmine flower extract in the preparation of a drug for preventing or treating metabolic syndrome and intestinal flora disorder, and in the preparation of a preparation of a special enrichment drug for Parabacteroides kingii. The present invention provides a basis for the study of the regulatory mechanism of jasmine flowers and their active ingredients for preventing and treating metabolic syndrome and intestinal health, and the jasmine flower extract can be used as a medicinal ingredient and the development and application of related drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of medical technology, and in particular to application of a frangipani flower extract in regulating intestinal flora and improving metabolic syndrome. Background Art

[0002] Obesity is a chronic disease characterized by excessive body fat, with multiple causes and the possibility of multiple complications. Obese people are more likely to suffer from type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease, cancer and other diseases.

[0003] At present, the treatment methods for obesity include diet therapy, exercise therapy, drug therapy and surgical therapy. Diet therapy is to limit the total calorie intake; exercise therapy is to formulate a plan under the guidance of a physician based on the patient's exercise volume, type, intensity, tolerance and other aspects; diet therapy and exercise therapy both require individualized treatment, and the treatment plan needs to be adjusted continuously according to the stage efficacy during the treatment process. Drug therapy includes weight loss drugs that act on the central and peripheral organs, but such drugs have side effects to varying degrees. Surgical therapy is only suitable for patients who have failed medical treatment and have serious complications. In the prior art, traditional Chinese medicine has a long history of understanding obesity, and various treatment methods are used, and most of them use "medicine and food are of the same origin" resources such as precious Chinese medicinal materials such as astragalus, ganoderma lucidum, cordyceps sinensis and their active ingredients, without obvious side effects. Therefore, it is urgent to develop new Chinese medicine resources as medicinal ingredients and related drugs for the treatment of obesity. Summary of the invention

[0004] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a use of a frangipani flower extract in regulating intestinal flora and improving metabolic syndrome.

[0005] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0006] The present invention uses the frangipani extract in the preparation of a drug for preventing or treating metabolic syndrome and intestinal flora disorder, and in the preparation of a preparation of a special enrichment drug for Parabacteroides kingii. Preferably, the frangipani extract is used in the preparation of a drug for preventing or treating obesity and related metabolic diseases.

[0007] Jasmine is a medicinal and edible plant of the genus Jasmine in the family Oleaceae, which has the effects of "soothing the liver and relieving depression, promoting qi and relieving pain". The inventors found that the Jasmine extract and its active ingredients oleuropein and hydroxytyrosol have good effects on improving metabolic syndromes such as obesity, non-alcoholic fatty liver disease, and diabetes. They can efficiently regulate the structure and composition of intestinal flora, such as selectively regulating certain flora, including Parabacteroides goldsteinii (PG). In addition, as a Chinese medicinal ingredient of "medicine and food homology" resources, oleuropein has a content of up to 80 mg / g in daily olive oil, and no toxic side effects have been found in long-term consumption, so it has high applicability in the fields of medicine and functional foods and has attracted much attention.

[0008] As a preferred embodiment of the use of the present invention, the frangipani flower extract contains oleuropein.

[0009] As a preferred embodiment of the application of the present invention, the preparation method of the frangipani flower extract is:

[0010] The dried buds of Jasmine jasmine are extracted with ethanol to obtain a filtrate, which is concentrated to obtain a crude extract; the crude extract is dissolved in water, extracted with petroleum ether, ethyl acetate and n-butanol in order, and the n-butanol layer extract is eluted on a macroporous resin column; the eluate is collected, and the solvent is evaporated to obtain the Jasmine jasmine flower extract.

[0011] As a preferred embodiment of the application of the present invention, the extraction is performed using 80% ethanol at room temperature and pressure.

[0012] As a preferred embodiment of the application of the present invention, when applying the macroporous resin column, 3 volumes of water, 10% ethanol, 20% ethanol and 5 volumes of 30% ethanol are used for elution in sequence; and the 30% ethanol eluate is collected.

[0013] The invention provides a medicine for preventing or treating metabolic syndrome or intestinal flora disorder, comprising a frangipani flower extract.

[0014] As a preferred embodiment of the medicine of the present invention, the metabolic syndrome is obesity and related metabolic diseases.

[0015] Compared with the prior art, the present invention has the following beneficial effects:

[0016] The present invention uses 16S rDNA amplicon sequencing technology and bioinformatics technology to analyze and find that the frangipani extract rich in oleuropein effectively regulates the structure and composition of the intestinal flora of obese mice and prevents the flora disorder caused by a high-fat diet. The frangipani extract can efficiently enrich intestinal Parabacteroides microorganisms, especially significantly enrich the new generation of probiotics-Parabacteroides kingii at the family, genus and species levels. Parabacteroides kingii has the potential to improve metabolic syndrome, and the frangipani extract can be developed and applied as a special enrichment drug for Parabacteroides kingii.

[0017] The present invention utilizes the "dirty cage sharing" cross-feeding technology to reveal that Parabacteroides kingii may mediate the anti-metabolic syndrome effect of Jasmine flower extract, and the bacterium can be used as a potential target for anti-metabolic syndrome.

[0018] The present invention provides a basis for studying the regulatory mechanism of jasmine flowers and their active ingredients in preventing and treating metabolic syndrome and intestinal health, and the jasmine flower extract can be used as a medicinal ingredient and the development and application of related drugs. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 The results of high performance liquid chromatography (HPLC) detection of jasmine crude extract (A) and oleuropein standard solution (B).

[0020] Figure 2 Jasmine flower extract improves metabolic syndrome via intestinal flora (n=8-10);

[0021] In the figure, (A) experimental process; (B) food intake; (C) weight gain; (DF) weight of epididymal, inguinal and perirenal WAT; (GI) plasma total cholesterol (CHO), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) levels.

[0022] Figure 3 Jasmine extract significantly improved the structure and composition of intestinal flora in obese mice (n=8);

[0023] In the figure, (A) Shannon index; (B) PCoA graph; (C) bacterial community composition at the phylum level.

[0024] Figure 4 The extract of Jasmine flower selectively enriched Parabacteroides kingii in the intestine of obese mice (n=8);

[0025] In the figure, (A) LEfSe analysis graph; (B) LDA graph of differential bacterial communities; (C) relative abundance of s_Parabacteroides_goldsteinii at the species level.

[0026] Figure 5The structure and composition of the intestinal flora of “dirty cage sharing” recipient mice (n=10);

[0027] In the figure, (A) Schematic diagram of the dirty cage sharing experiment; (B) Shannon index; (C) PCoA graph; (D) bacterial community composition at the phylum level.

[0028] Figure 6 Feeding donor mice with frangipani extract significantly increased the relative abundance of Parabacteroides kingii in the intestines of recipient mice (n=10);

[0029] In the figure, (A) LEfSe analysis graph; (B) LDA graph of differential bacterial communities; (C) relative abundance of s_Parabacteroides_goldsteinii at the species level.

[0030] Figure 7 Delivering the effect of frangipani extract on improving metabolic disorders to fecal microbiota (n=10);

[0031] In the figure, (A) weight gain of recipient mice; (B) food intake of recipient mice; (C) epididymal white fat (gWAT) content of recipient mice; (D) subcutaneous white fat (iWAT) content of recipient mice; (E) perirenal white adipose tissue (rpWAT) content of recipient mice; (F) plasma triglyceride (TG) content of recipient mice; (G) plasma total cholesterol (CHO) content of recipient mice; (H) low-density lipoprotein cholesterol (LDL-C) content of recipient mice; (I) plasma alanine aminotransferase (ALT) of recipient mice; (J) plasma aspartate aminotransferase (AST) of recipient mice. DETAILED DESCRIPTION

[0032] To better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments. It should be understood by those skilled in the art that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.

[0033] Unless otherwise specified, the experimental methods used in the examples are all conventional methods; the materials, reagents, etc. used, unless otherwise specified, can be obtained from commercial channels.

[0034] The present invention utilizes a high-fat diet-induced obese mouse model, combined with molecular biology and high-throughput multi-omics sequencing technologies, to systematically study the interaction between Parabacteroides kingii (PG) and oleuropein-rich frangipani extract (OJGF), further elucidating and exploring the role of Parabacteroides kingii in the anti-obesity effect of frangipani.

[0035] Example 1: Preparation of Jasmine Flower Extract

[0036] Take 8kg of dried buds of Jasmine needles, extract them three times with 80% ethanol at room temperature and pressure for about 72 hours, combine the filtrates of the three times, and concentrate them on a rotary evaporator to obtain 3.6kg of crude extract. After dissolving it in water, extract it in the order of petroleum ether, ethyl acetate and n-butanol, and the weights of the extracts are: 30g, 280g and 1300g. Take 240g of n-butanol layer extract and put it on a macroporous resin column, and elute it with 3 times the volume of water, 10% ethanol, 20% ethanol and 5 times the volume of 30% ethanol in turn. Collect 21 to 34 bottles of the 30% ethanol elution part, and evaporate the solvent on a rotary evaporator to obtain 58g of sample, i.e., Jasmine flower extract.

[0037] The oleuropein content was 69.8% as measured by high performance liquid chromatography (HPLC). The HPLC spectrum was detected at a wavelength of 280 nm. Figure 1 shown.

[0038] Example 2: Effects of Jasmine Flower Extract on Regulating Intestinal Flora and Improving Metabolic Syndrome

[0039] Mice fed with a high-fat diet (HFD) were given Jasmine extract for 8 weeks to observe the effect. Specifically: 7-week-old SPF-grade C57BL / 6J male mice were adapted to the environment for 1 week before the experiment (the same applies to other animal experiments below). All mice were fed with ordinary feed (Chow), HFD (45% fat calories) or HFD containing 0.024%, 0.12% and 0.6wt% Jasmine extract (oleuropein content of 69.8%) for 8 weeks at set time points. At the same time, the mice drank sterile water with or without antibiotic cocktail (1g / L ampicillin, 0.5g / L vancomycin, 1g / L neomycin and 1g / L metronidazole). The experimental groups were: normal group (Chow), model group (HFD), antibiotic group (ABX), low-dose jasmine flower extract group (OL), medium-dose group (OM), high-dose group (OH), and high-dose jasmine flower extract + ABX group (OH-ABX). The specific groups (8 mice / group) and the administration methods are detailed in Figure 1 A. Observe the changes in mouse body weight, body composition, biochemical indexes, intestinal flora structure and composition, etc.

[0040] like Figure 2 As shown: After the experiment, compared with the HFD diet mice, the weight gain and the weight of epididymal (gWAT), subcutaneous (iWAT) and perirenal (rpWAT) white fat of the Jasmine flower extract-treated mice, as well as the plasma ALT, AST, CHO, TG and LDL-C levels were reduced in a dose-dependent manner ( Figure 2BI), indicating that Jasmine flower extract has a good anti-obesity effect. After the antibiotic mixture ABX was used to deplete the intestinal flora, the weight gain and body fat content of mice intervened by Jasmine flower extract, as well as ALT, AST, CHO, TG and LDL-C in plasma did not change significantly. These results together indicate that Jasmine flower extract exerts its anti-obesity effect through the intestinal flora.

[0041] 16S rRNA amplicon sequencing was used to analyze the diversity and structure of the intestinal flora in the feces of each group of mice. The feces of mice were collected, frozen in liquid nitrogen, and sent to Beijing Biomarker Biotechnology Co., Ltd. on dry ice for sequencing analysis. In short, fecal DNA was extracted using the QIAGEN DNA Mini KIT kit, and the V3-V4 region of 16S DNA was amplified by PCR. Agarose gel electrophoresis and nucleic acid protein quantitative detection were performed to detect the purity and concentration of the extracted DNA. Qualified DNA was sequenced for 16S rDNA on the PacBio sequencing platform.

[0042] The analysis results are as follows Figure 3 and Figure 4 The results showed that 8 weeks of intervention with frangipani extract can effectively improve the structure and composition of intestinal flora in mice fed a HFD diet, increase the relative abundance of beneficial bacteria, especially the significant enrichment of Parabacteroides kingii (PG) at the family, genus and species levels, indicating that frangipani extract can effectively promote the growth of Parabacteroides kingii (PG) in vivo, which is beneficial to its anti-metabolic syndrome effect.

[0043] In order to further clarify the role of Parabacteroides kingii (PG) in the anti-obesity effect of frangipani extract, mice fed a HFD diet were cross-fed using "dirty cage sharing" for 8 weeks. The dirty cages of the frangipani extract-fed mice and HFD-fed mice were used to feed HFD-fed mice (i.e., HRecip group and ORecip group, 10 mice / group), respectively. The cages were changed twice a week for 8 weeks, and the changes in the structure and composition of the intestinal flora, body weight, body fat composition, blood sugar and blood lipids, liver function and other indicators of the recipient mice were detected.

[0044] like Figure 5 , Figure 6 and Figure 7 As shown in the figure, similar to the donor mice, the dirty cage feeding of mice treated with frangipani extract effectively reshaped the intestinal flora structure and composition of HFD-fed mice, especially the beneficial bacteria Parabacteroides kingii (PG), which was significantly enriched at the family, genus, and species levels ( Figure 5 and Figure 6 ). At the same time, the body weight, body weight gain, gWAT, iWAT and rpWAT weights, and plasma ALT, AST, CHO, TG and LDL-C levels of recipient mice were significantly reduced ( Figure 7), further suggesting that Parabacteroides kingii (PG) may play an important role in the improvement of metabolic syndrome by frangipani extract.

[0045] The formation and development of obesity are closely related to intestinal flora disorders. Targeting the intestinal flora and its metabolites to regulate related metabolic pathways has gradually become a new trend in the prevention and treatment of metabolic diseases. The present invention deeply analyzed the intestinal flora of mice on a HFD diet with oleuropein-rich frangipani extract and found that it can specifically enrich the intestinal microorganisms of the genus Parabacteroides in obese mice. The enrichment of this type of bacteria is beneficial to reduce the obesity caused by the HFD diet. Parabacteroides microorganisms may serve as new targets for the prevention and treatment of metabolic syndrome, and "medicinal and edible" plants can serve as an effective resource library for their development, providing new ideas and new targets for the precise intervention and new drug development in clinical anti-obesity and related metabolic diseases.

[0046] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. Use of Jasmine flower extract in the preparation of a drug for preventing or treating metabolic syndrome, It is characterized in that The metabolic syndrome is obesity; The preparation method of the jasmine flower extract comprises the following steps: taking dried buds of jasmine needles, extracting with ethanol to obtain a filtrate, and concentrating to obtain a crude extract; dissolving the crude extract in water, extracting the crude extract in the order of petroleum ether, ethyl acetate and n-butanol, and eluting the n-butanol layer extract on a macroporous resin column; collecting the eluate, and evaporating the solvent to obtain the jasmine flower extract; The extraction is carried out using 80% ethanol at normal temperature and pressure; When the macroporous resin column is applied, 3 volumes of water, 10% ethanol, 20% ethanol and 5 volumes of 30% ethanol are used for elution in sequence; and the 30% ethanol eluate is collected.

2. The use according to claim 1, It is characterized in that The frangipani flower extract contains oleuropein.